Severe Weather Resources Recursos el Clima Severo

Resources for Members During Severe Weather

If you are a Texas Children’s Health Plan Member, we have tips that can help you deal with the severe weather, click here.

Recursos para Miembros Durante el Clima Severo

Si eres miembro de Texas Children’s Health Plan, tenemos consejos que pueden ayudarte a lidiar con el clima severo. Haga clic aquí.

Important Update Actualización importante:

Good news! All CHIP, STAR, and STAR Kids Member Handbooks are now available online. Quick, easy access to your benefits and coverage information - any time!

¡Buenas noticias! Todos los manuales para miembros de CHIP, STAR y STAR Kids ya están disponibles en línea. Obtén acceso rápido y sencillo a la información sobre tus beneficios y cobertura, ¡en cualquier momento!

Medicaid Preferred Drug List and Formulary Changes Cambios en el formulario y la lista de medicamentos preferidos de Medicaid

The Vendor Drug Program (VDP) made changes to the Texas Medicaid drug formulary effective July 24, 2026. To learn more about formulary changes impacted, please click here for more information.

El programa de medicamentos de proveedores de Texas (VDP) ha realizado cambios recientes en el formulario de medicamentos de Medicaid de Texas. Esto entrará en vigencia el 24 de julio de 2026. Para obtener más información sobre los cambios en el formulario afectados, visite el siguiente enlace para obtener más información.

Search

RSV Season and Synagis Prior Authorization Ends On Schedule for All Health Service Regions

Date: March 24, 2026

Attention: Providers

Call to action: Vendor Drug Program (VDP) will end the 2025-26 respiratory syncytial virus season for all health service regions as scheduled. MCOs like Texas Children’s will no longer accept or review Synagis prior authorization requests once the region has closed. 2025-26 RSV Season Schedule

Background: Human Respiratory Syncytial Virus (RSV) causes respiratory tract infections and severe lung disease in infants and children. Synagis (palivizumab) is available for children with a high risk of infection.

How this impacts providers: Respiratory Syncytial Virus Treatment

Next step for Providers: Providers should share this information with the staff.

If you have any questions, please email Provider Relations at providerrelations@texaschildrens.org. 

For access to all provider alerts www.texaschildrenshealthplan.org/provideralerts.